0001808665-21-000005.txt : 20210212
0001808665-21-000005.hdr.sgml : 20210212
20210212180355
ACCESSION NUMBER: 0001808665-21-000005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210210
FILED AS OF DATE: 20210212
DATE AS OF CHANGE: 20210212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Peisert Daniel A.
CENTRAL INDEX KEY: 0001758376
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39294
FILM NUMBER: 21630510
MAIL ADDRESS:
STREET 1: C/O ASSERTIO THERAPEUTICS, INC.
STREET 2: 100 SOUTH SAUNDERS ROAD, SUITE 300
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Assertio Holdings, Inc.
CENTRAL INDEX KEY: 0001808665
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850598378
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 S. SAUNDERS ROAD
STREET 2: SUITE 300
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
BUSINESS PHONE: (224) 419-7106
MAIL ADDRESS:
STREET 1: 100 S. SAUNDERS ROAD
STREET 2: SUITE 300
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
4
1
wf-form4_161317101365578.xml
FORM 4
X0306
4
2021-02-10
0
0001808665
Assertio Holdings, Inc.
ASRT
0001758376
Peisert Daniel A.
ASSERTIO HOLDINGS, INC.
100 SOUTH SAUNDERS ROAD, SUITE 300
LAKE FOREST
IL
60045
1
1
0
0
President and CEO
Common Stock
2021-02-10
4
M
0
4087
0
A
207659
D
Common Stock
2021-02-10
4
F
0
1414
1.16
D
206245
D
Common Stock
2021-02-12
4
M
0
27587
0
A
233832
D
Common Stock
2021-02-12
4
F
0
9545
1.14
D
224287
D
Performance Shares
2021-02-10
4
M
0
4087
0
D
2021-02-10
2021-02-10
Common Stock
4087.0
0
D
Restricted Stock Units
2021-02-11
4
A
0
1834863
0
A
2024-02-11
Common Stock
1834863.0
1834863
D
Restricted Stock Units
2021-02-12
4
M
0
27587
0
D
2022-02-12
Common Stock
27587.0
27588
D
Represents shares of common stock withheld for payment of taxes upon the vesting of performance shares.
Represents shares of common stock withheld for payment of taxes upon the vesting of restricted stock units.
Each performance share represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested performance shares in shares of common stock.
The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
Each restricted stock unit represents a contingent right to receive one share of the registrant's common stock.
One-third of these restricted stock units are scheduled to vest on each of February 11, 2022, 2023 and 2024, assuming continued employment through the applicable vesting date.
Each restricted stock unit represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested restricted stock units in shares of common stock.
One-third of these restricted stock units are scheduled to vest on each of February 12, 2020, 2021 and 2022.
/s/ Jennifer Hipelius, attorney-in-fact for Daniel A. Peisert
2021-02-12